173 related articles for article (PubMed ID: 10229317)
21. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?
Wong KF; Chan JK
Br J Haematol; 1991 Apr; 77(4):509-14. PubMed ID: 2025576
[TBL] [Abstract][Full Text] [Related]
22. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis.
Török L; Kirschner A; Gurzó M; Krenács L
Eur J Dermatol; 2000 Aug; 10(6):463-5. PubMed ID: 10980469
[TBL] [Abstract][Full Text] [Related]
23. Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease.
Magro CM; Kiani B; Li J; Crowson AN
J Cutan Pathol; 2007 Jul; 34(7):526-34. PubMed ID: 17576331
[TBL] [Abstract][Full Text] [Related]
24. Stasis dermatitis-like leukaemic infiltration in a patient with myelodysplastic syndrome.
Papadavid E; Panayiotides I; Katoulis A; Pappa V; Dervenoulas I; Stavrianeas N
Clin Exp Dermatol; 2008 May; 33(3):298-300. PubMed ID: 18261141
[TBL] [Abstract][Full Text] [Related]
25. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
Martin de Frémont G; Hirsch P; Gimenez de Mestral S; Moguelet P; Ditchi Y; Emile JF; Senet P; Georgin-Lavialle S; Hanslik T; Maurier F; Adedjouma A; Abisror N; Mahevas T; Malard F; Adès L; Fenaux P; Fain O; Chasset F; Mekinian A
Front Immunol; 2021; 12():715053. PubMed ID: 34671345
[TBL] [Abstract][Full Text] [Related]
26. Testicular extramedullary myeloid cell tumor in a patient with myelodysplastic syndrome.
Saxena A; Saidman B; Greenwald D; Wasik MA
Arch Pathol Lab Med; 1996 Apr; 120(4):389-92. PubMed ID: 8619753
[TBL] [Abstract][Full Text] [Related]
27. Refractory anemia with an excess of blasts developed into overt leukemia with leukothrombocytosis.
Takahashi I; Togitani K; Yokoyama M; Aita T; Makihata K; Sunami K; Shiromoto M; Nakamura T; Kawada I; Nishimura M
Intern Med; 1995 Jan; 34(1):28-31. PubMed ID: 7718975
[TBL] [Abstract][Full Text] [Related]
28. Chronic relapsing remitting Sweet syndrome--a harbinger of myelodysplastic syndrome.
Kulasekararaj AG; Kordasti S; Basu T; Salisbury JR; Mufti GJ; du Vivier AW
Br J Haematol; 2015 Sep; 170(5):649-56. PubMed ID: 25962438
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
30. Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes.
Longacre TA; Smoller BR
Am J Clin Pathol; 1993 Sep; 100(3):276-84. PubMed ID: 8379536
[TBL] [Abstract][Full Text] [Related]
31. Management of unusual presentations of acute leukemia.
Baer MR
Hematol Oncol Clin North Am; 1993 Feb; 7(1):275-92. PubMed ID: 8449862
[TBL] [Abstract][Full Text] [Related]
32. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
[TBL] [Abstract][Full Text] [Related]
33. Pyoderma gangrenosum and myelodysplastic syndrome.
Litvak D; Kirsner RS; Pakdaman NN; Federman DG
South Med J; 2000 Sep; 93(9):923-5. PubMed ID: 11005358
[TBL] [Abstract][Full Text] [Related]
34. Extended cytogenetic follow-up of patients with myelodysplastic syndrome (MDS).
White AD; Culligan DJ; Hoy TG; Jacobs A
Br J Haematol; 1992 Aug; 81(4):499-502. PubMed ID: 1390235
[TBL] [Abstract][Full Text] [Related]
35. Juvenile myelomonocytic leukemia presenting multiple painful erythematous lesions diagnosed as Sweet's syndrome.
Kitamura H; Kaneko T; Nakano H; Terui K; Ito E; Sawamura D
J Dermatol; 2008 Jun; 35(6):368-70. PubMed ID: 18578716
[No Abstract] [Full Text] [Related]
36. Immature myeloid precursors in chronic neutrophilic dermatosis associated with myelodysplastic syndrome.
Tomasini C; Aloi F; Osella-Abate S; Dapavo P; Pippione M
Am J Dermatopathol; 2000 Oct; 22(5):429-33. PubMed ID: 11048979
[TBL] [Abstract][Full Text] [Related]
37. Erythematous Bullous Patch in a Patient With Myelodysplastic Syndrome: Challenge.
Hong JY; Park KY; Seo SJ
Am J Dermatopathol; 2018 Aug; 40(8):e109-e110. PubMed ID: 28375856
[No Abstract] [Full Text] [Related]
38. [Neoplastic skin infiltration in chronic myelomonocytic leukemia].
Wajs J; Zabielski S; Trawiński J
Pol Merkur Lekarski; 2001 Nov; 11(65):427-9. PubMed ID: 11852815
[TBL] [Abstract][Full Text] [Related]
39. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom.
Hiçsönmez G; Cetin M; Yenicesu I; Olcay L; Koç A; Aktaş D; Tunçbilek E; Tuncer M
Leuk Lymphoma; 2001 Aug; 42(4):665-74. PubMed ID: 11697496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
